Activation of EGFR, HER2 and HER3 by neurotensin/neurotensin receptor 1 renders breast tumors aggressive yet highly responsive to lapatinib and metformin in mice

por Dupouy, Sandra, Doan, Van Kien, Wu, Zherui, Mourra, Najat, Liu, Jin, De Wever, Olivier, Llorca, Frédérique Penault, Cayre, Anne, Kouchkar, Amal, Gompel, Anne, Forgez, Patricia
Publicado 2014